Achaogen Declares Chapter 11 with $25MM Financing Commitment from Si...

04/16/19

Achaogen Declares Chapter 11 with $25MM Financing Commitment from Silicon Valley Bank - News  ABL Advisor

Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) ...

[more]